Histogen Inc. (NASDAQ:HSTO – Get Free Report)’s share price traded up 533.3% during mid-day trading on Wednesday . The company traded as high as $0.19 and last traded at $0.19. 1,685,815 shares were traded during trading, an increase of 16,158% from the average session volume of 10,369 shares. The stock had previously closed at $0.03.
Histogen Stock Up 533.3 %
The stock has a market capitalization of $811,300.00, a PE ratio of -0.07 and a beta of 1.19. The firm’s fifty day moving average is $0.03 and its 200-day moving average is $0.11.
Histogen Company Profile
Histogen Inc, a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore immune function. The company’s product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases.
Further Reading
- Five stocks we like better than Histogen
- What is the Dogs of the Dow Strategy? Overview and Examples
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Airline Stocks – Top Airline Stocks to Buy Now
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Expert Stock Trading Psychology Tips
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Histogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Histogen and related companies with MarketBeat.com's FREE daily email newsletter.
